FDA Safety Page: Drug errors involving Keppra and Kaletra

Awards Honor Excellence and Improvement in Overall CMS Medicare Part D Star Ratings and PQA Medication Measures.

In the first episode of the podcast, Jennifer Goldman and Hailey Choi discuss the latest FDA updates around compounded weight loss medications, clinical concerns and how pharmacists can protect their patients.

Through digital innovations, transparency, and accessibility, pharmacists can help meet patients where they are at to improve their health outcomes.

Leveraging his expertise in pain management, Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, joined Drug Topics to discuss the importance of pharmacists in patients’ use of OTC medications to treat pain.

Researchers conducted a review of adherence behaviors for patients with dermatological diseases and provided an update on management strategies.

Glucagon-like peptide-1 medications are the fastest-growing class of medication and will continue to be prevalent as more indications, such as sleep apnea, are added.